Christiane Chen‐Santel

A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)

Erica Brivio, Franco Locatelli, Marta López‐Yurda et al. · Blood · 2020 · 90 citations · Full text

Medicine, Oncology, Pediatrics +17

Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial

Edoardo Pennesi, Naomi Michels, Erica Brivio et al. · Leukemia · 2022 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis

Franco Locatelli, Gerhard Zugmaier, Noemi Mergen et al. · Blood Advances · 2022 · 69 citations · Full text

Medicine, Hematology, Oncology +17

Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials

Cornelia Eckert, Catriona Parker, Anthony V. Moorman et al. · European Journal of Cancer · 2021 · 66 citations · Full text

Medicine, Hematology, Oncology +17

Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse

Stefanie Groeneveld‐Krentz, M. Schroeder, Michael J. Reiter et al. · British Journal of Haematology · 2019 · 38 citations · Full text

Medicine, Genetics, Hematology +17